Unique Blood Test Could Catch Cancer Early

Unique blood test could catch cancer early

First Early Endometrial Cancer Detection Test Launched by Gnosis

Gnosis recently launched EdenDx, the first commercially available, non-invasive, liquid-based cytology test in the U.S. for early-stage endometrial cancer detection. The test detects hypermethylation of two genes, CDO1 and CELF4, which are strongly associated with endometrial cancer. Until now, there have been no simple screening tests for endometrial cancer. To diagnose the disease, doctors mainly rely on symptoms, ultrasound, and biopsy. This …